[{"id":"2ed8ac1b-05a8-4919-930c-9b6f1bb7320a","acronym":"","url":"https://clinicaltrials.gov/study/NCT05277987","created_at":"2022-03-14T13:53:56.733Z","updated_at":"2024-07-02T16:36:15.503Z","phase":"Phase 1","brief_title":"An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects","source_id_and_acronym":"NCT05277987","lead_sponsor":"Shenzhen Fifth People's Hospital","biomarkers":" HER-2 • CLDN18","pipe":"","alterations":" ","tags":["HER-2 • CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HEC-016"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 03/01/2022","start_date":" 03/01/2022","primary_txt":" Primary completion: 03/01/2025","primary_completion_date":" 03/01/2025","study_txt":" Completion: 03/01/2025","study_completion_date":" 03/01/2025","last_update_posted":"2022-03-14"}]